Further clinical studies have shown that changes in the levels of the autophagy marker Beclin-1 are strongly associated with the response to medication for depression and that Beclin-1 may serve as an independent predictor of the efficacy of medication for depression [96]. The gene discussed is BECN1; the disease is depressive symptom measurement.